These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
313 related items for PubMed ID: 24482015
1. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Wang Z, Li K, Dong K, Xiao X, Zheng S. Pediatr Blood Cancer; 2014 Aug; 61(8):1518-9. PubMed ID: 24482015 [No Abstract] [Full Text] [Related]
2. Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Chiu YE, Drolet BA, Blei F, Carcao M, Fangusaro J, Kelly ME, Krol A, Lofgren S, Mancini AJ, Metry DW, Recht M, Silverman RA, Tom WL, Pope E. Pediatr Blood Cancer; 2012 Nov; 59(5):934-8. PubMed ID: 22648868 [Abstract] [Full Text] [Related]
4. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma. Wang H, Guo X, Duan Y, Zheng B, Gao Y. Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213 [Abstract] [Full Text] [Related]
5. Sirolimus therapy for children with problematic kaposiform haemangioendothelioma and tufted angioma. Tasani M, Ancliff P, Glover M. Br J Dermatol; 2017 Dec; 177(6):e344-e346. PubMed ID: 28485019 [No Abstract] [Full Text] [Related]
6. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment. Hermans DJ, van Beynum IM, van der Vijver RJ, Kool LJ, de Blaauw I, van der Vleuten CJ. J Pediatr Hematol Oncol; 2011 May; 33(4):e171-3. PubMed ID: 21516018 [Abstract] [Full Text] [Related]
8. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma. Zhang X, Yang K, Chen S, Ji Y. J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046 [Abstract] [Full Text] [Related]
9. Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol. Filippi L, Tamburini A, Berti E, Perrone A, Defilippi C, Favre C, Calvani M, Della Bona ML, la Marca G, Donzelli G. Pediatr Blood Cancer; 2016 Jul; 63(7):1290-2. PubMed ID: 27100060 [Abstract] [Full Text] [Related]
10. Treatment of kaposiform hemangioendothelioma and tufted angioma. Liu XH, Li JY, Qu XH, Yan WL, Zhang L, Yang C, Zheng JW. Int J Cancer; 2016 Oct 01; 139(7):1658-66. PubMed ID: 27252149 [Abstract] [Full Text] [Related]
13. Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma. Liu X, Li J, Qu X, Yan W, Zhang L, Zhang S, Yang C, Zheng J. Medicine (Baltimore); 2016 May 01; 95(20):e3431. PubMed ID: 27196448 [Abstract] [Full Text] [Related]
14. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus. Jahnel J, Lackner H, Reiterer F, Urlesberger B, Urban C. Klin Padiatr; 2012 Oct 01; 224(6):395-7. PubMed ID: 23070861 [No Abstract] [Full Text] [Related]
16. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants. Wang Y, Kong L, Sun B, Cui J, Shen W. J Craniofac Surg; 2020 Jun 01; 31(4):1074-1077. PubMed ID: 32176003 [Abstract] [Full Text] [Related]
17. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine. Barabash-Neila R, García-Rodríguez E, Bernabeu-Wittel J, Bueno-Rodríguez I, Ramírez-Villar G, López-Gutierrez JC. Indian J Pediatr; 2012 Oct 01; 79(10):1386-7. PubMed ID: 22161581 [No Abstract] [Full Text] [Related]
18. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES. Benzar IM, Rebenkov SO, Levytskyi AF, Fedoniuk LY, Fomina LV, Sas LM, Stravskyy TY. Wiad Lek; 2020 Oct 01; 73(8):1785-1789. PubMed ID: 33055352 [Abstract] [Full Text] [Related]